Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2012, Article ID 956137, 10 pages
http://dx.doi.org/10.1155/2012/956137
Research Article

Effect of Hypericum perforatum Extract in an Experimental Model of Binge Eating in Female Rats

1School of Pharmacy, Pharmacology Unit, University of Camerino, 62032 Camerino, Italy
2Department of Biomedical Sciences, University of Modena and Reggio Emilia, 41100 Modena, Italy

Received 10 February 2012; Revised 31 July 2012; Accepted 1 August 2012

Academic Editor: Kristin Schneider

Copyright © 2012 Maria Vittoria Micioni Di Bonaventura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Psychiatric Association. Diagnostic and statistic manual of mental disorders, IV-TR Washington, 2000.
  2. B. T. Walsh and M. J. Devlin, “Eating disorders: progress and problems,” Science, vol. 280, no. 5368, pp. 1387–1390, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. J. I. Hudson, E. Hiripi, H. G. Pope Jr., and R. C. Kessler, “The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication,” Biological Psychiatry, vol. 61, no. 3, pp. 348–358, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. K. N. Javaras, H. G. Pope Jr., J. K. Lalonde et al., “Co-occurrence of binge eating disorder with psychiatric and medical disorders,” Journal of Clinical Psychiatry, vol. 69, no. 2, pp. 266–273, 2008. View at Google Scholar · View at Scopus
  5. R. A. Grucza, T. R. Przybeck, and C. R. Cloninger, “Prevalence and correlates of binge eating disorder in a community sample,” Comprehensive Psychiatry, vol. 48, no. 2, pp. 124–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Fassino, P. Leombruni, A. Pierò, G. Abbate-Daga, and G. G. Rovera, “Mood, eating attitudes, and anger in obese women with and without Binge Eating Disorder,” Journal of Psychosomatic Research, vol. 54, no. 6, pp. 559–566, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. W. F. Mathes, K. A. Brownley, X. Mo, and C. M. Bulik, “The biology of binge eating,” Appetite, vol. 52, no. 3, pp. 545–553, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. C. Heath, “Binge-eating and bulimia: potential insights into etiology and pathophysiology through genetic epidemiologic studies,” Biological Psychiatry, vol. 44, no. 12, pp. 1208–1209, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Devlin, S. Z. Yanovski, and G. T. Wilson, “Obesity: what mental health professionals need to know,” American Journal of Psychiatry, vol. 157, no. 6, pp. 854–866, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Z. Yanovski, “Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic?” International Journal of Eating Disorders, vol. 34, supplement, pp. S117–S120, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wardle, A. Steptoe, G. Oliver, and Z. Lipsey, “Stress, dietary restraint and food intake,” Journal of Psychosomatic Research, vol. 48, no. 2, pp. 195–202, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. L. M. Y. Freeman and K. M. Gil, “Daily stress, coping, and dietary restraint in binge eating,” International Journal of Eating Disorders, vol. 36, no. 2, pp. 204–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Polivy, S. B. Zeitlin, C. P. Herman, and A. L. Beal, “Food restriction and binge eating: a study of former prisoners of war,” Journal of Abnormal Psychology, vol. 103, no. 2, pp. 409–411, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. H. Wong, P. Lewindon, R. Mortimer, and R. Shepherd, “Internal and external antecedents of binge eating episodes in a group of women with bulimia nervosa,” International Journal of Eating Disorders, vol. 29, no. 1, pp. 17–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Stice, W. S. Agras, C. F. Telch, K. A. Halmi, J. E. Mitchell, and T. Wilson, “Subtyping binge eating-disordered women along dieting and negative affect dimensions,” International Journal of Eating Disorders, vol. 30, no. 1, pp. 11–27, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. J. H. Crowther, J. Sanftner, D. Z. Bonifazi, and K. L. Shepherd, “The role of daily hassles in binge eating,” International Journal of Eating Disorders, vol. 29, no. 4, pp. 449–454, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. G. E. Wolff, R. D. Crosby, J. A. Roberts, and D. A. Wittrock, “Differences in daily stress, mood, coping, and eating behavior in binge eating and nonbinge eating college women,” Addictive Behaviors, vol. 25, no. 2, pp. 205–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. National Institute for Clinical Excellence, “Eating disorders-core interventions in the treatment and management of anorexia nervosa, bulimia nervosa, and related eating disorders,” NICE Clinical Guideline no 9, NICE, London, UK, 2004. View at Google Scholar
  19. S. L. McElroy, N. A. Shapira, L. M. Arnold et al., “Topiramate in the long-term treatment of binge-eating disorder associated with obesity,” Journal of Clinical Psychiatry, vol. 65, no. 11, pp. 1463–1469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. McElroy, J. I. Hudson, J. A. Capece, K. Beyers, A. C. Fisher, and N. R. Rosenthal, “Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study,” Biological Psychiatry, vol. 61, no. 9, pp. 1039–1048, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Appolinario, A. Godoy-Matos, L. F. Fontenelle et al., “An open-label trial of sibutramine in obese patients with binge-eating disorder,” Journal of Clinical Psychiatry, vol. 63, no. 1, pp. 28–30, 2002. View at Google Scholar · View at Scopus
  22. D. E. Wilfley, S. J. Crow, J. I. Hudson et al., “Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study,” American Journal of Psychiatry, vol. 165, no. 1, pp. 51–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. L. McElroy, A. I. Guerdjikova, B. Martens, P. E. Keck Jr., H. G. Pope Jr., and J. I. Hudson, “Role of antiepileptic drugs in the management of eating disorders,” CNS Drugs, vol. 23, no. 2, pp. 139–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. W. P. Carter, J. I. Hudson, J. K. Lalonde, L. Pindyck, S. L. McElroy, and H. G. Pope Jr., “Pharmacologic treatment of binge eating disorder,” International Journal of Eating Disorders, vol. 34, supplement, pp. S74–S88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Yager, “Binge eating disorder: the search for better treatments,” American Journal of Psychiatry, vol. 165, no. 1, pp. 4–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. DRUGDEX System [Internet Database], Thomson Reuters (Healthcare), Greenwood Village, Colo, USA, 2010.
  27. M. S. Gold, K. Frost-Pineda, and W. S. Jacobs, “Overeating, binge eating, and eating disorders as addictions,” Psychiatric Annals, vol. 33, no. 2, pp. 117–122, 2003. View at Google Scholar · View at Scopus
  28. M. L. Pelchat, A. Johnson, R. Chan, J. Valdez, and J. D. Ragland, “Images of desire: food-craving activation during fMRI,” NeuroImage, vol. 23, no. 4, pp. 1486–1493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. N. M. Avena, P. Rada, and B. G. Hoebel, “Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake,” Neuroscience and Biobehavioral Reviews, vol. 32, no. 1, pp. 20–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. R. Ifland, H. G. Preuss, M. T. Marcus et al., “Refined food addiction: a classic substance use disorder,” Medical Hypotheses, vol. 72, no. 5, pp. 518–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. N. Gearhardt, W. R. Corbin, and K. D. Brownell, “Food addiction: an examination of the diagnostic criteria for dependence,” Journal of Addiction Medicine, vol. 3, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. G. Hoebel, “Brain neurotransmitters in food and drug reward,” American Journal of Clinical Nutrition, vol. 42, no. 5, pp. 1133–1150, 1985. View at Google Scholar · View at Scopus
  33. N. D. Volkow and R. A. Wise, “How can drug addiction help us understand obesity?” Nature Neuroscience, vol. 8, no. 5, pp. 555–560, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. R. L. Corwin, N. M. Avena, and M. M. Boggiano, “Feeding and reward: perspectives from three rat models of binge eating,” Physiology and Behavior, vol. 104, no. 1, pp. 87–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. N. Gearhardt, S. Yokum, P. T. Orr, E. Stice, W. R. Corbin, and K. D. Brownell, “Neural correlates of food addiction,” Archives of General Psychiatry, vol. 68, no. 8, pp. 808–816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. G. J. Wang, A. Geliebter, N. D. Volkow et al., “Enhanced striatal dopamine release during food stimulation in binge eating disorder,” Obesity, vol. 19, no. 8, pp. 1601–1608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. M. Boggiano, P. C. Chandler, J. B. Viana, K. D. Oswald, C. R. Maldonado, and P. K. Wauford, “Combined dieting and stress evoke exaggerated responses to opioids in binge-eating rats,” Behavioral Neuroscience, vol. 119, no. 5, pp. 1207–1214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Buda-Levin, F. H. E. Wojnicki, and R. L. Corwin, “Baclofen reduces fat intake under binge-type conditions,” Physiology and Behavior, vol. 86, no. 1-2, pp. 176–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. R. L. Corwin and F. H. Wojnicki, “Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions,” Behavioural Pharmacology, vol. 20, no. 5-6, pp. 537–548, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Cifani, C. Polidori, S. Melotto, R. Ciccocioppo, and M. Massi, “A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam,” Psychopharmacology, vol. 204, no. 1, pp. 113–125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. I. Broft, A. Spanos, R. L. Corwin et al., “Baclofen for binge eating: an open-label trial,” International Journal of Eating Disorders, vol. 40, no. 8, pp. 687–691, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Meyer, “Alleviation of both binge eating and sexual dysfunction with naltrexone,” Journal of Clinical Psychopharmacology, vol. 28, no. 6, pp. 722–723, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Arbaizar, I. Gómez-Acebo, and J. Llorca, “Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review,” General Hospital Psychiatry, vol. 30, no. 5, pp. 471–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Perfumi, R. Ciccocioppo, S. Angeletti, M. Cucculelli, and M. Massi, “Effects of Hypericum perforatum extract on alcohol intake in Marchigian Sardinian alcohol-preferring rats,” Alcohol and Alcoholism, vol. 34, no. 5, pp. 690–698, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Perfumi, R. Ciccocioppo, S. Angeletti, M. Cucculelli, and M. Massi, “Effects of Hypericum perforatum extract on alcohol intake in Marchigtan Sardinian alcohol-preferring rats,” Alcohol and Alcoholism, vol. 34, no. 5, pp. 690–698, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Panocka, M. Perfumi, S. Angeletti, R. Ciccocioppo, and M. Massi, “Effects of Hypericum perforatum extract on ethanol intake, and on behavioral despair—a search for the neurochemical systems involved,” Pharmacology Biochemistry and Behavior, vol. 66, no. 1, pp. 105–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Perfumi, M. Santoni, A. Cippitelli, R. Ciccocioppo, R. Froldi, and M. Massi, “Hypericum perforatum CO2-extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats,” Alcoholism, vol. 27, no. 10, pp. 1554–1562, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. A. H. Rezvani, D. H. Overstreet, M. Perfumi, and M. Massi, “Plant derivatives in the treatment of alcohol dependency,” Pharmacology Biochemistry and Behavior, vol. 75, no. 3, pp. 593–606, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. D. H. Overstreet, W. M. Keung, A. H. Rezvani, M. Massi, and D. Y. W. Lee, “Herbal remedies for alcoholism: promises and possible pitfalls,” Alcoholism, vol. 27, no. 2, pp. 177–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Perfumi, L. Mattioli, L. Forti, M. Massi, and R. Ciccocioppo, “Effect of Hypericum perforatum CO2 extract on the motivational properties of ethanol in alcohol-preferring rats,” Alcohol and Alcoholism, vol. 40, no. 4, pp. 291–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Barnes, L. A. Anderson, and J. D. Phillipson, “St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties,” Journal of Pharmacy and Pharmacology, vol. 53, no. 5, pp. 583–600, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Loakmann, “St. John's Wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy,” Pharmacopsychiatry, vol. 31, no. 1, pp. 54–59, 1998. View at Google Scholar · View at Scopus
  53. K. Linde and C. D. Mulrow, “St John's wort for depression,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD000448, 2000. View at Google Scholar · View at Scopus
  54. H. P. Volz, “Controlled clinical trials of hypericum extracts in depressed patients—an overview,” Pharmacopsychiatry, vol. 30, no. 2, pp. 72–76, 1997. View at Google Scholar · View at Scopus
  55. S. V. Vormfelde, W. Poser, and B. Gaster, “Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression,” Archives of Internal Medicine, vol. 160, no. 16, pp. 2548–2549, 2000. View at Google Scholar · View at Scopus
  56. V. Butterweck, “Effects of the total extract and fractions of hyper/cum perforatum in animal assays for antidepressant activity,” Pharmacopsychiatry, vol. 30, no. 2, pp. 117–124, 1997. View at Google Scholar · View at Scopus
  57. S. S. Chatterjee, S. K. Bhattacharya, M. Wonnemann, A. Singer, and W. E. Müller, “Hyperforin as a possible antidepressant component of hypericum extracts,” Life Sciences, vol. 63, no. 6, pp. 499–510, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Gambarana, O. Ghiglieri, P. Tolu et al., “Efficacy of an Hypericum perforatum (St. John's Wort) extract in preventing and reverting a condition of escape deficit in rats,” Neuropsychopharmacology, vol. 21, no. 2, pp. 247–257, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Gambarana, P. L. Tolu, F. Masi et al., “A study of the antidepressant activity of Hypericum perforatum on animal models,” Pharmacopsychiatry, vol. 34, no. 1, pp. S42–S44, 2001. View at Google Scholar · View at Scopus
  60. P. J. Nathan, “The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.),” Molecular Psychiatry, vol. 4, no. 4, pp. 333–338, 1999. View at Google Scholar · View at Scopus
  61. M. Perfumi, I. Panocka, R. Ciccocioppo, D. Vitali, R. Froldi, and M. Massi, “Effects of a methanolic extract and a hyperforin-enriched CO2 extract of hypericum perforatum on alcohol intake in rats,” Alcohol and Alcoholism, vol. 36, no. 3, pp. 199–206, 2001. View at Google Scholar · View at Scopus
  62. A. Nahrstedt, “Biologically active and other chemical constituents of the herb of Hypericum perforation L,” Pharmacopsychiatry, vol. 30, no. 2, pp. 129–134, 1997. View at Google Scholar · View at Scopus
  63. A. G. Jensen, S. H. Hansen, and E. Ø. Nielsen, “Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity,” Life Sciences, vol. 68, no. 14, pp. 1593–1605, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Wirz, U. Simmen, J. Heilmann, I. Çalis, B. Meier, and O. Sticher, “Bisanthraquinone glycosides of Hypericum perforatum with binding inhibition to CRH-1 receptors,” Phytochemistry, vol. 55, no. 8, pp. 941–947, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. U. Simmen, J. Higelin, K. Berger-Büter, W. Schaffner, and K. Lundstrom, “Neurochemical studies with St. John's wort in vitro,” Pharmacopsychiatry, vol. 34, supplement 1, pp. S137–S142, 2001. View at Google Scholar · View at Scopus
  66. U. Simmen, I. Bobirnac, C. Ullmer et al., “Antagonist effect of pseudohypericin at CRF1 receptors,” European Journal of Pharmacology, vol. 458, no. 3, pp. 251–256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Roos, C. Röseler, K. B. Büter, and U. Simmen, “Classification and correlation of St. John's wort extracts by nuclear magnetic resonance spectroscopy, multivariate data analysis and pharmacological activity,” Planta Medica, vol. 70, no. 8, pp. 771–777, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. V. Butterweck, M. Hegger, and H. Winterhoff, “Flavonoids of St. John's Wort reduce HPA axis function in the rat,” Planta Medica, vol. 70, no. 10, pp. 1008–1011, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. O. Grundmann, Y. Lv, O. Kelber, and V. Butterweck, “Mechanism of St. John's wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system,” Neuropharmacology, vol. 58, no. 4-5, pp. 767–773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Crupi, E. Mazzon, A. Marino et al., “Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice,” BMC Complementary and Alternative Medicine, vol. 11, article 7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Panossian and H. Wagner, “Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration,” Phytotherapy Research, vol. 19, no. 10, pp. 819–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Panossian and G. Wikman, “Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity,” Current Clinical Pharmacology, vol. 4, no. 3, pp. 198–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Cifani, M. V. Micioni Di, G. Vitale, V. Ruggieri, R. Ciccocioppo, and M. Massi, “Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating,” Physiology and Behavior, vol. 101, no. 5, pp. 555–562, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. M. M. Hagan, P. K. Wauford, P. C. Chandler, L. A. Jarrett, R. J. Rybak, and K. Blackburn, “A new animal model of binge eating: key synergistic role of past caloric restriction and stress,” Physiology and Behavior, vol. 77, no. 1, pp. 45–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Perfumi, I. Panocka, R. Ciccocioppo, D. Vitali, R. Froldi, and M. Massi, “Effects of a methanolic extract and a hyperforin-enriched CO2 extract of Hypericum perforatum on alcohol intake in rats,” Alcohol and Alcoholism, vol. 36, no. 3, pp. 199–206, 2001. View at Google Scholar · View at Scopus
  76. B. M. V. Micioni Di, C. Cifani, R. Ciccocioppo, and M. Massi, “Influence of the ovarian cycle on binge eating evoked in female rats by stress and food restrictions,” Appetite, vol. 54, article 663, 2010. View at Google Scholar
  77. S. F. Akana, C. S. Cascio, and J. Z. Du, “Reset of feedback in the adrenocortical system: an apparent shift in sensitivity of adrenocorticotropin to inhibition by corticosterone between morning and evening,” Endocrinology, vol. 119, no. 5, pp. 2325–2332, 1986. View at Google Scholar · View at Scopus
  78. G. Vitale, R. Arletti, V. Ruggieri, C. Cifani, and M. Massi, “Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats,” Peptides, vol. 27, no. 9, pp. 2193–2200, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. P. V. Piazza, V. Deroche, J. M. Deminiere, S. Maccari, M. Le Moal, and H. Simon, “Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 11738–11742, 1993. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Dellu, P. V. Piazza, W. Mayo, M. Le Moal, and H. Simon, “Novelty-seeking in rats biobehavioral characteristics and possible relationship with the sensation-seeking trait in man,” Neuropsychobiology, vol. 34, no. 3, pp. 136–145, 1996. View at Google Scholar · View at Scopus
  81. J. R. Mantsch, D. Saphier, and N. E. Goeders, “Corticosterone facilitates the acquisition of cocaine self- administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone,” Journal of Pharmacology and Experimental Therapeutics, vol. 287, no. 1, pp. 72–80, 1998. View at Google Scholar · View at Scopus
  82. U. Shalev, M. Marinelli, M. H. Baumann, P. V. Piazza, and Y. Shaham, “The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat,” Psychopharmacology, vol. 168, no. 1-2, pp. 170–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. B. M. V. Micioni Di, C. Cifani, K. C. Rice, R. Ciccocioppo, and M. Massi, “Effect of the CRF-1 receptor antagonist R121919 on binge eating,” Appetite, vol. 57S, article S30, 2011. View at Google Scholar
  84. G. F. Koob, “A role for brain stress system in addiction,” Neuron, vol. 59, no. 1, pp. 11–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. R. Ciccocioppo, D. Economidou, A. Cippitelli et al., “Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism,” Addiction Biology, vol. 11, no. 3-4, pp. 339–355, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. V. Butterweck, H. Winterhoff, and M. Herkenham, “Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats,” Neuropsychopharmacology, vol. 28, no. 12, pp. 2160–2168, 2003. View at Google Scholar · View at Scopus
  87. A. Panossian, G. Wikman, P. Kaur, and A. Asea, “Adaptogens stimulate neuropeptidey and Hsp72 expression and release in neuroglia cells,” Frontiers in Neuroscience, vol. 6, article 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. A. A. Ammar, R. Nergårdh, B. B. Fredholm, U. Brodin, and P. Södersten, “Intake inhibition by NPY and CCK-8: a challenge of the notion of NPY as an ‘orexigen’,” Behavioural Brain Research, vol. 161, no. 1, pp. 82–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. F. Sederholm, A. A. Ammar, and P. Södersten, “Intake inhibition by NPY: role of appetitive ingestive behavior and aversion,” Physiology and Behavior, vol. 75, no. 4, pp. 567–575, 2002. View at Publisher · View at Google Scholar · View at Scopus